Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies

Opioid-substance use disorder is a major health issue across North America. Opioid-related overdose is the primary cause of death for people age 18-35 years in North America (Gomes et al., 2014; Park and Bloch, 2016), and several treatment options exist (e.g., treatment centers (TCs), extended release naltrexone, or extended release buprenorphine). Opioid agonist therapy, including methadone maintenance treatment (MMT), is one of the most common treatment options, and it is the standard of care for patients with opioid substance use disorder in Ontario, Canada (Ball and Ross, 1991; Bart, 2012; Luce and Strike, 2011).
Source: Drug and Alcohol Dependence - Category: Addiction Authors: Tags: Full length article Source Type: research